A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this clinical study is to find out what happens to kidney and heart health during treatment with a medicine called semaglutide, which is given as an injection under the skin. The clinical study will also look at whether this medicine is safe for adults who have type 2 diabetes (T2D) and chronic kidney disease (CKD). This study will last for about 60 to 172 weeks.
Epistemonikos ID: 57ab98951cc9f1b78408767378e7c473f1c56b3d
First added on: Oct 29, 2026